ALKS
Ticker
Alkermes plc
ALKS · Healthcare · Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to addres…Alkermes plc (ALKS), in the Healthcare sector, has 22 disclosed filings on Paydirt over the trailing twelve months from 1 member of Congress and 6 corporate insiders: 1 purchase and 21 sales. Filers took a median of 0 days from execution to disclosure, and the most recent trade was executed Sep 1 and filed Sep 1. The most active filer was Craig C. Hopkinson with 21 filings.
Add to watchlistFilings, ttm
22
1 buy · 21 sells
Traders, ttm
7
1 congress · 6 insiders
Volume, ttmiDollar value disclosed in the window
$9.8M
estimated for Congress, as filed for insiders
Median delay
0d
execution to disclosure
Last traded
Sep 1
Filed Sep 1
ADViAverage daily dollar volume
$102.7M
market data
Share price · 12M
$46.10 (+66.8%)
Adjusted for splits and dividends.
Volume by month
Buys $33K
Sells $30.1M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
CHRecent filings
Gilbert CisnerosPURCHASE
Representative
$33K$15K–50K bracket
Exec Jul 30
Filed Sep 4 Craig C. HopkinsonSALE EVP R&D, Chief Medical Officer $423K
9,000 sh × $46.99
Exec Sep 1
Filed Sep 1 · 7:08 PM ET Christian Todd NicholsSALE SVP, Chief Commercial Officer $340K
6,912 sh × $49.19
Exec Aug 17
Filed Aug 17 · 6:53 PM ET nancy lynn MD snydermanSALE Director $2.2M
44,472 sh × $50.35
Exec Aug 3
Filed Aug 3 · 7:16 PM ET Craig C. HopkinsonSALE EVP R&D, Chief Medical Officer $437K
9,000 sh × $48.58
Exec Aug 3
Filed Aug 3 · 7:12 PM ET David Joseph GaffinSALE EVP, CLO, Alkermes, Inc. $110K
2,034 sh × $54.03
Exec Jul 6
Filed Jul 6 · 4:48 PM ET Craig C. HopkinsonSALE EVP R&D, Chief Medical Officer $427K
8,300 sh × $51.46
Exec Jul 1
Filed Jul 1 · 6:29 PM ET Craig C. HopkinsonSALE EVP R&D, Chief Medical Officer $375K
9,000 sh × $41.67
Exec Jun 1
Filed Jun 1 · 5:30 PM ET Samuel Joseph ParisiSALE VP, Finance (Interim PAO) $687K
16,217 sh × $42.36
Exec May 29
Filed May 29 · 5:30 PM ET Craig C. HopkinsonSALE EVP R&D, Chief Medical Officer $301K
9,000 sh × $33.40
Exec May 1
Filed May 1 · 5:30 PM ET Craig C. HopkinsonSALE EVP R&D, Chief Medical Officer $320K
9,000 sh × $35.51
Exec Apr 1
Filed Apr 1 · 5:30 PM ET Craig C. HopkinsonSALE EVP R&D, Chief Medical Officer $267K
9,000 sh × $29.72
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Christian Todd NicholsSALE SVP, Chief Commercial Officer $180K
6,000 sh × $30.00
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Samuel Joseph ParisiSALE VP, Finance (Interim PAO) $202K
6,890 sh × $29.29
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Shane CookeSALE Director $2.1M
61,200 sh across 2 lots
Exec Feb 2
Filed Feb 2 · 5:30 PM ET Craig C. HopkinsonSALE EVP R&D, Chief Medical Officer $305K
9,000 sh across 2 lots
Exec Feb 2
Filed Feb 2 · 5:30 PM ET Craig C. HopkinsonSALE EVP R&D, Chief Medical Officer $150K
5,000 sh × $30.00
Exec Jan 8
Filed Jan 8 · 5:30 PM ET Craig C. HopkinsonSALE EVP R&D, Chief Medical Officer $112K
4,000 sh × $28.00
Exec Jan 2
Filed Jan 2 · 5:30 PM ET Craig C. HopkinsonSALE EVP R&D, Chief Medical Officer $112K
3,748 sh × $30.00
Exec Dec 3 2025
Filed Dec 5 2025 · 5:30 PM ET Craig C. HopkinsonSALE EVP R&D, Chief Medical Officer $117K
4,000 sh × $29.30
Exec Dec 1 2025
Filed Dec 1 2025 · 5:30 PM ET Craig C. HopkinsonSALE EVP R&D, Chief Medical Officer $273K
9,000 sh × $30.38
Exec Nov 3 2025
Filed Nov 3 2025 · 5:30 PM ET Craig C. HopkinsonSALE EVP R&D, Chief Medical Officer $284K
9,000 sh × $31.53
Exec Oct 15 2025
Filed Oct 15 2025 · 5:30 PM ET Christian Todd NicholsSALE SVP, Chief Commercial Officer $210K
6,667 sh across 2 lots
Exec Jun 9 2025
Filed Jun 10 2025 · 5:30 PM ET Samuel Joseph ParisiSALE VP, Finance (Interim PAO) $132K
3,743 sh × $35.26
Exec Feb 25 2025
Filed Feb 25 2025 · 5:30 PM ET Craig C. HopkinsonSALE EVP R&D, Chief Medical Officer $11.8M
349,340 sh across 4 lots
Exec Feb 12 2025
Filed Feb 14 2025 · 5:30 PM ET